A novel immunosuppression-based classification of liver tumors opens new perspectives for adapted therapeutic strategies

• Kevin Bévant,
• Cédric Coulouarn

Affiliations

Kevin Bévant

Inserm, CHU Pontchaillou, 2 rue Henri Le Guilloux, F-35033 Rennes, France

Cédric Coulouarn

Corresponding author.; Inserm, CHU Pontchaillou, 2 rue Henri Le Guilloux, F-35033 Rennes, France